Install
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Unlocking cell surface protein research with site-specific labeling
7+ hour, 46+ min ago (900+ words) BioSpace...
Heartbeat By Sound: Scientists Develop Non-Invasive Pacemaker — ABN TV
11+ hour, 52+ min ago (700+ words) What if a person who needs a pacemaker no longer had to undergo surgery to have one implanted? Imagine having no wires threaded into the heart, no pulse generator implanted under the skin and, potentially, no repeat procedures to deal…...
The eastward shift in the biotech world: Why India and China could lead the next wave
16+ hour, 16+ min ago (747+ words) China’s advantage is scale across discovery and development, and India in cost-efficiency and innovation footprint. For decades, the global biotechnology map was largely defined by a handful of established centres in the United States, and Europe. Boston, the Bay Area,…...
Jewish Megadonor Resumes $100 Million Harvard Gift After Pause Over Campus Antisemitism
15+ hour, 45+ min ago (377+ words) CAMBRIDGE, MASSACHUSETTS (VINnews) — A Jewish billionaire who froze a $100 million pledge to Harvard University after the Oct. 7, 2023, Hamas attacks on Israel has agreed to resume the gift, following two years of outreach by the university’s president and changes addressing campus…...
Heartbeat by sound: Scientists develop non-invasive pacemaker
17+ hour, 58+ min ago (738+ words) What if a person who needs a pacemaker no longer had to undergo surgery to have one implanted? Imagine having no wires threaded into the heart, no pulse generator implanted under the skin and, potentially, no repeat procedures to deal…...
Servier Partnering Day: Connecting Pharma, Biotech, and Academia for New Opportunities - OncoDaily
20+ hour, 21+ min ago (107+ words) Servier shared on LinkedIn: “We are excited to announce that the next edition of the Servier Partnering Day will take place in our Paris-Saclay R/D Institute on November 23rd! This unique event is designed to bring together pharma and biotech…...
Nurses to sympathy strike, picket on September 15 at five Prime Healthcare hospitals in four states
1+ day, 1+ hour ago (370+ words) Since the suspension of the Olympia Fields nurses, two of the suspended nurses have been fired as well as a nurse at Saint Francis Hospital in Evanston, Illinois, and three nurses at Central Maine Medical Center have been suspended — all…...
These 3 Mass. colleges have the 'highest payoff,' according to Forbes
21+ hour, 46+ min ago (299+ words) Three Massachusetts schools have been ranked among Forbes’ picks for the 25 colleges and universities nationwide with the highest payoffs. Massachusetts Institute of Technology (MIT), Harvard University, and Williams College all made the list, ranking at 12, 13, and 17, respectively. To determine each…...
Phase III TAISHAN-302 Trial Shows Tam-Peli Significantly Improves Survival in Relapsed Small-Cell Lung Cancer
1+ day, 4+ hour ago (164+ words) Sep 13, 2026, 08:57 ET Anti-B7-H3 antibody-drug conjugate reduced the risk of death by 54% versus topotecan and improved progression-free survival and response rates Relapsed SCLC remains a highly aggressive disease with limited effective treatment options and poor outcomes following first-line immunotherapy and platinum-based…...
Roche’s collaborator MediLink announces phase III data for Tam-Peli showing significantly improved overall survival in Chinese patient population with relapsed small-cell lung cancer
1+ day, 17+ hour ago (328+ words) Tambotatug pelitecan (Tam-Peli) demonstrated statistically significant efficacy over topotecan in a phase III study conducted in China, reducing the risk of death by 54% and disease progression by 71%, while achieving an objective response rate of 59.1% vs 9.7%1 The novel B7-H3-targeted antibody-drug conjugate…...